69 related articles for article (PubMed ID: 9340511)
21. [Otorhinolaryngologic localization of malignant lymphomas associated with HIV infection. A new factor in erroneous prognosis?].
Garnier G; Taillan B; Pesce A; Fuzibet JG; Cassuto JP; Dujardin P
Presse Med; 1992 Nov; 21(40):1915. PubMed ID: 1293607
[No Abstract] [Full Text] [Related]
22. Advances in the management of HIV-related non-Hodgkin lymphoma.
Behler CM; Kaplan LD
Curr Opin Oncol; 2006 Sep; 18(5):437-43. PubMed ID: 16894290
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk in HIV-infected persons: influence of CD4(+) count.
Clifford GM; Franceschi S
Future Oncol; 2009 Jun; 5(5):669-78. PubMed ID: 19519206
[TBL] [Abstract][Full Text] [Related]
24. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D
Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436
[TBL] [Abstract][Full Text] [Related]
25. Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients.
Tirelli U; Errante D; Spina M; Gastaldi R; Nigra E; Nosari AM; Magnani G; Vaccher E
Cancer; 1996 May; 77(10):2127-31. PubMed ID: 8640681
[TBL] [Abstract][Full Text] [Related]
26. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Rossi G; Donisi A; Casari S; Re A; Stellini R; Cadeo G; Carosi G
Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
[TBL] [Abstract][Full Text] [Related]
27. Treatment of localized lymphoma.
Hoecht S; Hinkelbein W
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948267
[No Abstract] [Full Text] [Related]
28. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
Vaccher E; Spina M; Talamini R; Zanetti M; di Gennaro G; Nasti G; Tavio M; Bernardi D; Simonelli C; Tirelli U
Clin Infect Dis; 2003 Dec; 37(11):1556-64. PubMed ID: 14614680
[TBL] [Abstract][Full Text] [Related]
29. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
30. [Indirect endolymphatic chemotherapy of patients with lymphoma].
Kindzel'skiĭ LP; Gubareva AA
Vrach Delo; 1989 Jun; (6):64-6. PubMed ID: 2781767
[TBL] [Abstract][Full Text] [Related]
31. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
Mounier N; Spina M; Gisselbrecht C
Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
[TBL] [Abstract][Full Text] [Related]
32. Acquired immunodeficiency syndrome-associated lymphomas.
Freter CE
J Natl Cancer Inst Monogr; 1990; (10):45-54. PubMed ID: 2189476
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
34. [Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity].
Nie DH; Hu WH; Gao YH; Wu Y; Zhang SP
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):312-4. PubMed ID: 15312373
[TBL] [Abstract][Full Text] [Related]
35. [Malignant lymphoma associated with HIV infection].
Mitrou PS; Serke M; Pohl C; Becker K; Schrappe-Bächer M; Knauf W; Westerhausen M; Clemens MR; Helm EB; Fischer T
Dtsch Med Wochenschr; 1991 Aug; 116(33):1217-23. PubMed ID: 1874122
[TBL] [Abstract][Full Text] [Related]
36. Malignant lymphomas in patients with or at risk for AIDS: a report of 50 cases observed in Italy.
Monfardini S; Tirelli U; Vaccher E; Ambrosini A; Andriani A; Silvestroni IB; Broccia G; Chisesi T; Fassio F; Deliliers GL
Cancer Detect Prev; 1988; 12(1-6):237-41. PubMed ID: 3180128
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Spina M; Simonelli C; Tirelli U
J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
[No Abstract] [Full Text] [Related]
38. Non-Hodgkin's lymphoma in AIDS.
Majchrowicz M
GMHC Treat Issues; 1995 Nov; 9(11):7-10. PubMed ID: 11362993
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy in the Rwandan countryside: universal issues a world away.
Postow M
Ann Intern Med; 2012 Jan; 156(1 Pt 1):60-1. PubMed ID: 22213499
[No Abstract] [Full Text] [Related]
40. Dose intensity and lymphoma.
Meyer R; Goodyear M; Hryniuk W
J Clin Oncol; 1991 Aug; 9(8):1511. PubMed ID: 2072151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
